BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
DNMT1
,
T cell differentiation
,
Arthritis
,
Intestine
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CDK4/6
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thymus gland
Stomach pyloric
Bone marrow
Stomach cardiac
Stomach fundus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Lymphoid leukemia
Retinal detachment
Pyloric ulcer
Toxic effect of mycotoxin
Meningitis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
cyanazine
trabectedin
Zalypsis
Methylnitronitrosoguanidine
isonicotinamide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
C15orf65
SETD1B
VPS26A
PTCH1
CIITA
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Development of PROTAC degrader probe of CDK4/6 based on DCAF16.
Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast C…
METTL9 derived circular RNA circ-METTL9 sponges miR-551b-5p to accelerate colorectal cancer progress…
The prognostic significance of CDK6 expression in renal cell carcinoma treated by immune checkpoint …
Phenotype Identification of HeLa Cells Knockout CDK6 Gene Based on Label-Free Raman Imaging.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer
A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumo…
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced…
LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)
Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II T…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ